2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$262.99+$3.06 (+1.18%)
Price as of Oct 02, 2026 3:23 PM EDT- $459.3BMarket Cap
- 13.29%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$262.99+$3.06 (+1.18%)
Earnings Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 4.05% | ||
12-Month Momentum | 9.69% | ||
3-Month Risk Adjusted Momentum | 38.39% | ||
12-Month Risk Adjusted Momentum | 38.66% |
True Yield
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 2.66% | ||
Net Buyback Yield | 0.34% | ||
Net Debt Paydown Yield | 0.53% |
Financial Health Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 9 |